Aline de Conti , Federica Madia, Mary K. Schubauer-Berigan, Lamia Benbrahim-Tallaa
{"title":"Carcinogenicity of some metals evaluated by the IARC Monographs: A synopsis of the evaluations of arsenic, cadmium, cobalt, and antimony","authors":"Aline de Conti , Federica Madia, Mary K. Schubauer-Berigan, Lamia Benbrahim-Tallaa","doi":"10.1016/j.taap.2025.117506","DOIUrl":null,"url":null,"abstract":"<div><div>Metals represent a major area of concern due to their extensive industrial applications, environmental persistence, and well-documented adverse health effects. Notably, metals (and metalloids) such as arsenic, cadmium, beryllium, chromium, cobalt, lead, and nickel are known for their toxicity and carcinogenic potential, raising significant public health concerns. Human exposure to these metals occurs through different routes, posing both environmental and workplace hazards. The <em>Monographs</em> programme of the International Agency for Research on Cancer (IARC) plays a critical role in identifying carcinogenic hazards to humans, providing a robust scientific foundation for global actions to prevent cancer. This review focuses on selected metals and metalloids: arsenic, cadmium, cobalt, and antimony, emphasizing how the IARC evaluation process considers the biological properties of the metals and their compounds, and the evidence from experimental animal studies and mechanistic data, including the application of the key characteristics of carcinogens (KCs) framework, in determining carcinogenic potential. The <em>IARC Monographs</em> contribute to a comprehensive understanding of metal-induced carcinogenicity and reinforce the importance of systematic, evidence-based approaches to inform public health interventions and regulatory decision-making.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"504 ","pages":"Article 117506"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X25002820","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Metals represent a major area of concern due to their extensive industrial applications, environmental persistence, and well-documented adverse health effects. Notably, metals (and metalloids) such as arsenic, cadmium, beryllium, chromium, cobalt, lead, and nickel are known for their toxicity and carcinogenic potential, raising significant public health concerns. Human exposure to these metals occurs through different routes, posing both environmental and workplace hazards. The Monographs programme of the International Agency for Research on Cancer (IARC) plays a critical role in identifying carcinogenic hazards to humans, providing a robust scientific foundation for global actions to prevent cancer. This review focuses on selected metals and metalloids: arsenic, cadmium, cobalt, and antimony, emphasizing how the IARC evaluation process considers the biological properties of the metals and their compounds, and the evidence from experimental animal studies and mechanistic data, including the application of the key characteristics of carcinogens (KCs) framework, in determining carcinogenic potential. The IARC Monographs contribute to a comprehensive understanding of metal-induced carcinogenicity and reinforce the importance of systematic, evidence-based approaches to inform public health interventions and regulatory decision-making.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.